Wednesday, September 13, 2017

Healthtalk Live, Inc. (OTCQB: HLTK) announces that FINRA has approved the company's request to change its name to Right On Brands; The ticker symbol will also change from HLTK to RTON on the OTCQB market

Healthtalk Live, Inc. (OTCQB: HLTK) announces that FINRA has approved the company's request to change its name to Right On Brands; The ticker symbol will also change from HLTK to RTON on the OTCQB market



LOS ANGELES, CA - September 13, 2017 (Investorideas.com Newswire) Healthtalk Live, Inc. (OTCQB: HLTK) - The name Right on Brands symbolizes the focus the company is taking in the health and wellness space. "The next trillion dollar industry globally, the Health & Wellness market is dominated mostly by beauty and anti-aging product sales at $679 billion, followed by fitness and mind and body exercise ($390 billion) and healthy eating, nutrition and weight loss sales ($277 billion)" (Women's Marketing). Spearheaded by its brand Humbly Hemp, RTON will continue to invest in and develop amazing brands in the categories of Superfoods Products, Naturally Alkaline Water, and Cannabis through its three subsidiary companies: Humbly Hemp, Humble Water Co., and Endo Brands.

Humbly Hemp, which launched three months ago, is marketing and selling its hemp based snack line in 20+ retail locations in Los Angeles, online and is available on Amazon.com. These snacks are powered with functional superfoods and hemp protein. They are certified gluten free, kosher, naturally flavored, and low in sugar. These nutritious and sustainable snacks are ideal for on the go worry free snacking.


Disclosure: Healthtalk Live, Inc. (OTCQB:HLTK) is featured on the 420 Cannabis Investor Ideas Directory at www.420cannabisinvestorideas.com

 


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure RTON is a featured PR, social media and news client on Investorideas.com effective July 27 2017 – More info: http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


#Biotech/Cannabinoid Stock News: Scythian Biosciences Corp. (TSXV: $SCYB.V) Appoints Former VP of ( $CELG) as Chief Scientific Officer

#Biotech/Cannabinoid Stock News: Scythian Biosciences Corp. (TSXV: $SCYB.V) Appoints Former VP of ( $CELG) as  Chief Scientific Officer

Former Vice President of the Chiral Pharmaceutical Business Unit at Celgene Corporation (NASDAQ: $CELG) Joins Scythian Biosciences



TORONTO - September 13, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (the "Company") (TSXV: SCYB) reports that Maghsoud Dariani has become the Chief Scientific Officer of the Company. Mr. Dariani was previously on the Company's advisory board and has over 35 years of experience in the development and commercialization of products in the pharmaceutical industry. Mr. Dariani's experience includes, among other things, management positions at Semorex, Focus Pharmaceuticals, Celgene and Chiral Pharmaceuticals.


Scythian Biosciences Corp. (TSX.V: SCYB)
is a Featured biotech and marijuana company on Investorideas.com


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country

Tuesday, September 12, 2017

Revive Therapeutics (TSX VENTURE:RVV) (OTCQB:RVVTF) Advances Research Program of #Cannabinoid-Based Drug Delivery Technology for the Medical Marijuana and Pharmaceutical Markets

Revive Therapeutics (TSX VENTURE:RVV) (OTCQB:RVVTF) Advances Research Program of #Cannabinoid-Based Drug Delivery Technology for the Medical Marijuana and Pharmaceutical Markets

TORONTO, ONTARIO - September 12, 2017 (Investorideas.com Newswire) Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs, today announced the advancement of the research program with the University of Wisconsin-Madison to evaluate a novel drug delivery technology with a focus on cannabinoids for the potential to treat various diseases, such as pain and inflammation for the medical marijuana and pharmaceutical markets for Canada and the United States. The Company intends to develop novel therapies and partner with licensed medical marijuana producers and partner with pharmaceutical companies requiring a unique and validated drug delivery technology for their development and commercial therapeutic pipelines.





Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing



Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Monday, September 11, 2017

Rev. Al Sharpton Headlines Cannabis World Congress And Business Exposition In Los Angeles Thursday

Rev. Al Sharpton Headlines Cannabis World Congress And Business Exposition In Los Angeles Thursday

New York, NY - September 11, 2017 (Investorideas.com Newswire) National Action Network Founder and President Rev. Al Sharpton will give the keynote address at the annual Cannabis World Congress and Business Exposition Thursday, discussing the rampant inequality in the marijuana industry and disproportionate arrests of people of color.

People of Color are 2-4 times more likely to be arrested in marijuana arrests, and despite massive growth in the business, minorities are still vastly underrepresented in key business opportunities like dispensary ownership.





Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


#Hemp Stock News: CSE New Listing – Eviana Health Corporation (EHC)

#Hemp Stock News: CSE New Listing – Eviana Health Corporation (EHC)

September 11, 2017 (Investorideas.com Newswire) The Canadian Securities Exchange, or CSE reports the common shares of Eviana Health Corporation have been approved for listing on the CSE.



Listing and disclosure documents will be available at http://thecse.com/.

Eviana Health Corporation's aim is to deliver customized consumer skin care products using natural hemp strains of cannabis sativa for cosmeceutical and nutraceutical merchandise and cannabinoid-based topical creams and products.





Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Supporters of Regulating Marijuana for Adult Use Will Hold News Conference Tomorrow (Tues.)

Supporters of Regulating Marijuana for Adult Use Will Hold News Conference Tomorrow (Tues.)

Current and former state and municipal leaders will join the Connecticut Coalition to Regulate Marijuana to express support for making marijuana legal and taxing it to help ease state and local budget issues

HARTFORD, Conn. - September 11, 2017 (Investorideas.com Newswire) The Connecticut Coalition to Regulate Marijuana will host a news conference on Tuesday with local municipal leaders to promote making marijuana legal for adults as a way to help fix budget issues in Connecticut. The coalition will urge lawmakers to consider regulating and taxing marijuana similarly to alcohol to help balance the state budget, create jobs, and diversify the sources of revenue available to local municipalities. The news conference will take place in Room 1E of the Legislative Office Building at 12 p.m.




Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Thursday, September 7, 2017

Federal Government Survey Shows Teen Marijuana Use Dropped in 2016

Federal Government Survey Shows Teen Marijuana Use Dropped in 2016

National Survey on Drug Use and Health reported teen marijuana use at lowest rate since 2002; increase in adult marijuana use coincides with decreases in alcohol use in all age groups, suggesting possible substitution

WASHINGTON - September 7, 2017 (Investorideas.com Newswire) The annual National Survey on Drug Use and Health released Thursday by the Substance Abuse and Mental Health Services Administration (SAMHSA) reports that teen marijuana use rates decreased nationally in 2016. Past-month use rates among adults increased slightly, but alcohol use rates among all age groups decreased, indicating the possibility that adults are substituting marijuana for alcohol.






Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.